Machine learning identifies metabolic dysfunction associated steatotic liver disease in patients with diabetes mellitus.
Katarzyna NabrdalikHanna KwiendaczKrzysztof IrlikMirela HendelKarolina DrożdżAgata M WijataJakub NalepaOliwia JanotaWiktoria WójcikJanusz GumprechtGregory Y H LipPublished in: The Journal of clinical endocrinology and metabolism (2024)
A ML approach demonstrated high performance in identifying MASLD in patients with DM. This approach may facilitate better risk stratification and cardiovascular risk prevention strategies for high-risk patients with DM at risk of MASLD.